Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Cancer MedicineOpen Access

Development of a Mitochondrial Permeability Transition‐Driven Necrosis‐Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single‐Cell Data

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJiaojiao NiuSSSreenivasan Sasidharan

Discussion

Loading...

Member takes

Overview

Regression analyses identified key genes in cervical cancer, suggesting MPT-driven necrosis impacts prognosis.

Key Points

  • A novel prognostic risk signature linked to mitochondrial permeability transition was developed for cervical cancer.
  • Analysis identified three key genes—ICOS, MMP3, and POSTN—that are important for prognosis in cervical cancer.
  • The methodology incorporated bulk transcriptomic data, independent validation, and risk stratification for survival predictions.
  • The findings suggest that targeting MMP3 and POSTN may enhance therapeutic options in treating cervical cancer.

Cite This Study

Niu et al. (2025) studied this question.

synapsesocial.com/papers/68c23f1fb210217d64794db7https://doi.org/10.1002/cam4.71094
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and validation of mitochondrial metabolism-related genes in the prognostic and immunological characterization of clear cell renal cell carcinoma2025
  2. 2Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development2025
  3. 3Constructing a novel mitochondrial-related gene signature for predicting survival and evaluating the tumor immune microenvironment in clear cell renal cell carcinoma2025
  4. 4Novel Metabolic‐Prognostic Integration Reveals TCF21‐Mediated Mitochondrial Regulation in Endometrial Cancer2025
  5. 5Identification of Anoikis‐Related Subgroups and Prognosis Model in Colon Cancer2025